Benitec Website, page-10

"share price tells you everything you need to know".

That is true of all company share prices at all times. If the share price goes down then the company is hopeless, the management are incompetent, anyone buying the shares is an idiot, and the only geniuses around are the shorters. If the share price goes up then the company is great, the management know what they are doing, everyone should buy the shares, and short?? ha ha not me.

Trouble is, share prices can sometimes go up one day and down the next, and then do it again. Fact is, today's share price doesn't tell you anything about who's a feather duster and who's a rooster or wonderhen.

In BLT's case, the share price is pretty well set for failure, with market cap not far above cash. With the trials having succeeded to date bar "one mild treatment-related effect", and with "Dosing into first subject of Cohort 4" still "anticipated Q4 2015", there is a strong case for the share price to reflect a non-trivial percentage of the profit that will ensue if the trials succeed and the treatments go on the market. The share price is telling you that BLT a screaming buy for those who can afford to take the risk. That is "everything you need to know".